Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tyler Bloomer"'
Autor:
Tyler Bloomer, Pete Fong, Breck Sandvall, Chandan Devireddy, Wissam Jaber, Gautam Kumar, Henry A. Liberman, Michael C. McDaniel, Georges El-Hayek
Publikováno v:
Catheterization and Cardiovascular Interventions. 89:754-760
Objectives To evaluate the safety and efficacy of catheter-directed thrombolysis (CDT) in the treatment of acute pulmonary embolism (PE). Background The use of CDT for the treatment of acute submassive and massive PE is increasing in frequency. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9d0328afcabe5147e73f7e04cb1f09b
https://doi.org/10.1002/ccd.26900
https://doi.org/10.1002/ccd.26900
Publikováno v:
Journal of the American College of Cardiology. 70:B39-B40
Catheter-directed thrombolysis (CDT) in the treatment of acute pulmonary embolism (PE) aims to reduce bleeding complications while maintaining efficacy compared to systemic fibrinolysis. While studies have shown CDT to have superior hemodynamic outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f75fb2cbd1c0df53e93091c57f3d641
https://doi.org/10.1016/j.jacc.2017.09.146
https://doi.org/10.1016/j.jacc.2017.09.146
Publikováno v:
Journal of the American College of Cardiology. 71:A2287
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1437fec97ec30d6f0722c1689dce3721
https://doi.org/10.1016/s0735-1097(18)32828-6
https://doi.org/10.1016/s0735-1097(18)32828-6
Publikováno v:
Critical pathways in cardiology. 14(3)
Background The ideal treatment strategy for acute pulmonary embolism (PE) remains a subject of debate. Treatment strategies vary based on numerous factors including the clinical scenario, hemodynamic variables, PE location, and personnel who are trai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63a17c26715e267ca64c91b8e8318183
https://pubmed.ncbi.nlm.nih.gov/26214811
https://pubmed.ncbi.nlm.nih.gov/26214811
Autor:
Tyler Bloomer, Pete Fong, Breck Sandvall, Wissam Jaber, Michael C. McDaniel, Henry A. Liberman, Chandan Devireddy
Publikováno v:
Journal of the American College of Cardiology. 68:B315-B316
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e795c40e57d013308959bf26204fbc11
https://doi.org/10.1016/j.jacc.2016.09.812
https://doi.org/10.1016/j.jacc.2016.09.812
Autor:
Douglas B. Johnson, Matthew R Alexander, Daniel J. Lenihan, Javid Moslehi, David Slosky, Tyler Bloomer, Jeffrey A. Sosman, Jason R Becker
Publikováno v:
Journal of the American College of Cardiology. 69:943
Background: Immune checkpoint inhibitors have expanded treatment options for a number of cancer types by enhancing anti-tumor immune responses. Specifically, ipilimumab, an anti-cytotoxic T-lymphocyte associated antigen 4 (CTLA-4) antibody, and nivol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::970f182365e20ce45518c14408df9f7f
https://doi.org/10.1016/s0735-1097(17)34332-2
https://doi.org/10.1016/s0735-1097(17)34332-2
Publikováno v:
Journal of the American College of Cardiology. 69:1159
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec90554ae85d32afe3fb53e678aaff29
https://doi.org/10.1016/s0735-1097(17)34548-5
https://doi.org/10.1016/s0735-1097(17)34548-5
Autor:
Christopher Ellis, Tyler Bloomer
Publikováno v:
Journal of the American College of Cardiology. 69:2135
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb93df73c417facd8b21e3dab9b5f90c
https://doi.org/10.1016/s0735-1097(17)35524-9
https://doi.org/10.1016/s0735-1097(17)35524-9